MedPath
HSA Approval

RAMEZOL CAPSULE 20 mg

SIN12166P

RAMEZOL CAPSULE 20 mg

RAMEZOL CAPSULE 20 mg

January 15, 2003

SHOEI UNIVERSAL CORPORATION PTE LTD

SHOEI UNIVERSAL CORPORATION PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSHOEI UNIVERSAL CORPORATION PTE LTD
Licence HolderSHOEI UNIVERSAL CORPORATION PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

A02BC01

omeprazole

Manufacturer Information

SHOEI UNIVERSAL CORPORATION PTE LTD

HANMI PHARM CO LTD

Active Ingredients

OMEPRAZOLE

20 mg

Omeprazole

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.